Deep Track Capital, LP 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:32 am Sale | 2023-12-31 | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital, LP | 0 0.000% | -3,952,000 (Position Closed) | Filing |
| 2023-02-14 08:21 am Purchase | 2022-12-31 | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital, LP | 3,952,000 9.660% | 1,537,083 (+63.65%) | Filing |
| 2022-01-27 4:34 pm Purchase | 2022-01-24 | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital, LP | 2,414,917 5.970% | 2,414,917 (New Position) | Filing |